Acadia Healthcare (NASDAQ:ACHC) Price Target Cut to $70.00

Acadia Healthcare (NASDAQ:ACHC) had its price target decreased by Mizuho from $84.00 to $70.00 in a report released on Friday, Benzinga reports. Mizuho currently has a neutral rating on the stock.

Other research analysts also recently issued reports about the stock. Stephens raised shares of Acadia Healthcare from an equal weight rating to an overweight rating and set a $92.00 price target for the company in a report on Friday, January 5th. Barclays reduced their target price on Acadia Healthcare from $100.00 to $91.00 and set an overweight rating for the company in a research report on Thursday. TD Cowen lifted their price target on Acadia Healthcare from $86.00 to $101.00 and gave the company an outperform rating in a research report on Friday, March 1st. Cantor Fitzgerald reissued a neutral rating and set a $90.00 price objective on shares of Acadia Healthcare in a report on Tuesday, March 5th. Finally, Bank of America dropped their target price on shares of Acadia Healthcare from $105.00 to $90.00 and set a buy rating for the company in a research report on Thursday. One analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of Moderate Buy and an average price target of $88.89.

Acadia Healthcare Trading Down 0.9 %

NASDAQ:ACHC opened at $66.12 on Friday. The company has a market cap of $6.11 billion, a P/E ratio of -472.25, a P/E/G ratio of 1.95 and a beta of 1.31. Acadia Healthcare has a 1 year low of $64.74 and a 1 year high of $87.77. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 0.67. The stock’s fifty day moving average price is $76.77 and its two-hundred day moving average price is $77.52.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, May 1st. The company reported $0.84 earnings per share for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The business had revenue of $768.10 million during the quarter, compared to analyst estimates of $779.20 million. During the same quarter in the previous year, the firm earned $0.75 EPS. The company’s quarterly revenue was up 9.1% compared to the same quarter last year. As a group, analysts expect that Acadia Healthcare will post 3.56 EPS for the current year.

Insider Transactions at Acadia Healthcare

In related news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Raymond James & Associates grew its holdings in Acadia Healthcare by 0.6% in the 3rd quarter. Raymond James & Associates now owns 76,048 shares of the company’s stock worth $5,347,000 after acquiring an additional 424 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of Acadia Healthcare by 1.1% during the third quarter. Bank of New York Mellon Corp now owns 1,258,459 shares of the company’s stock worth $88,482,000 after purchasing an additional 13,765 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Acadia Healthcare by 20.1% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 18,920 shares of the company’s stock worth $1,330,000 after purchasing an additional 3,167 shares during the last quarter. Mackenzie Financial Corp increased its holdings in Acadia Healthcare by 1.3% during the 3rd quarter. Mackenzie Financial Corp now owns 15,737 shares of the company’s stock valued at $1,063,000 after purchasing an additional 199 shares during the period. Finally, Strs Ohio raised its position in Acadia Healthcare by 14.2% during the 3rd quarter. Strs Ohio now owns 74,188 shares of the company’s stock valued at $5,216,000 after purchasing an additional 9,200 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.